...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Two opposite signaling outputs are driven by the KIR2DL1 receptor in human CD4+ T cells.
【24h】

Two opposite signaling outputs are driven by the KIR2DL1 receptor in human CD4+ T cells.

机译:人类CD4 + T细胞中的KIR2DL1受体驱动两个相反的信号输出。

获取原文
获取原文并翻译 | 示例

摘要

Inhibitory killer Ig-like receptors (KIR), expressed by human natural killer cells and effector memory CD8(+) T-cell subsets, bind HLA-C molecules and suppress cell activation through recruitment of the Src homology 2 domain-containing protein tyrosine phosphatase 1 (SHP-1). To further analyze the still largely unclear role of inhibitory KIR receptors on CD4(+) T cells, KIR2DL1 transfectants were obtained from a CD4(+) T-cell line and primary cells. Transfection of CD4(+) T cells with KIR2DL1 dramatically increased the T-cell receptor (TCR)-induced production of interleukin-2 independently of ligand binding but inhibited TCR-induced activation after ligation. KIR-mediated costimulation of TCR activation involves intact KIR2DL1-ITIM phosphorylation, SHP-2 recruitment, and PKC- phosphorylation. Synapses leading to activation were characterized by an increase in the recruitment of p-Tyr, SHP-2, and p-PKC-, but not of SHP-1. Interaction of KIR2DL1 with its ligand led to a strong synaptic accumulation of KIR2DL1 and the recruitment of SHP-1/2, inhibiting TCR-induced interleukin-2 production. KIR2DL1 may induce 2 opposite signaling outputs in CD4(+) T cells, depending on whether the KIR receptor is bound to its ligand. These data highlight unexpected aspects of the regulation of T cells by KIR2DL1 receptors, the therapeutic manipulation of which is currently being evaluated.
机译:由人类自然杀伤细胞和效应器记忆CD8(+)T细胞亚群表达的抑制性杀伤性Ig样受体(KIR),结合HLA-C分子并通过募集Src同源2域蛋白酪氨酸磷酸酶来抑制细胞活化1(SHP-1)。为了进一步分析CD4(+)T细胞上抑制性KIR受体的作用还不清楚,从CD4(+)T细胞系和原代细胞中获得了KIR2DL1转染子。用KIR2DL1转染CD4(+)T细胞可显着增加T细胞受体(TCR)诱导的白细胞介素2的产生,而与配体结合无关,但在连接后抑制TCR诱导的活化。 KIR介导的TCR激活的共刺激涉及完整的KIR2DL1-ITIM磷酸化,SHP-2募集和PKC-磷酸化。导致激活的突触的特征是增加p-Tyr,SHP-2和p-PKC-的募集,但不增加SHP-1的募集。 KIR2DL1及其配体的相互作用导致KIR2DL1强烈的突触积累和SHP-1 / 2的募集,从而抑制TCR诱导的白介素2的产生。 KIR2DL1可能会在CD4(+)T细胞中诱导2个相反的信号输出,具体取决于KIR受体是否与其配体结合。这些数据突显了KIR2DL1受体调节T细胞的意想不到的方面,目前正在评估其治疗性操作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号